Safety and Efficacy Study of CFI-402411 in Subjects With Advanced Solid Malignancies
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Omid Hamid, Dr
The Angeles Clinic, Los Angeles
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cross Cancer Institute
Edmonton, Alberta, Canada
- the Ottawa Hospital
Ottawa, Ontario, Canada
- Princess Margaret Cancer Centre
Toronto, Ontario, Canada
- Prince of Wales Hospital
Shatin, Hong Kong
- University of California San Diego
La Jolla, California, United States
- the Angeles Clinic
Los Angeles, California, United States
- Yale Cancer Center
New Haven, Connecticut, United States
- Florida Cancer Specialists
Sarasota, Florida, United States
- Start - Mid-West
Grand Rapids, Michigan, United States
- Scri - Nashville
Nashville, Tennessee, United States
- Md Anderson
Houston, Texas, United States
- Start - San Antonio
San Antonio, Texas, United States
- Virginia Cancer Specialist
Fairfax, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2020
- Primary completion
- 30 Nov 2025
- Completion
- 31 Dec 2025
- Last update posted
- 21 May 2025
- Registered enrollment
- 170
- Registry id
- NCT04521413
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.